http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0276369-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 |
| filingDate | 1987-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1991-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0276369-B1 |
| titleOfInvention | Use of anipamil in the treatment of arteriosclerosis |
| abstract | Anipamil and its salts with physiologically tolerated acids are used for the preparation of drugs having antiarteriosclerotic properties and in the treatment of arteriosclerosis. |
| priorityDate | 1986-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.